259 results on '"Hammond, Milton L."'
Search Results
2. In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa
3. Discovery of betamethasone 17α-carbamates as dissociated glucocorticoid receptor modulators in the rat
4. Antagonist-Induced, Activation Function-2-Independent Estrogen Receptor α Phosphorylation
5. Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties
6. The fungal cell wall as a drug discovery target: SAR of novel echinocandin analogs
7. Chapter 13. Recent Advances in Anti-Infective Agents
8. Synthesis and SAR of thioester and thiol inhibitors of IMP-1 Metallo-β-Lactamase
9. Dicationic 2-fluorenonylcarbapenems: Potent anti-MRS agents with improved solubility and pharmacokinetic properties
10. Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
11. SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors
12. Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712
13. Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii
14. 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: Scaffold design and advancement in HDLc-raising efficacy
15. 2-Arylbenzoxazoles as CETP inhibitors: Raising HDL-C in cynoCETP transgenic mice
16. 19-Hydroxy-IOS (19)-Dihydrovitamin D3 and 25-Hydroxy-24-norvitamin D3 : Analogs with Anti-Metabolite Activity and Related Studies
17. Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A
18. Design of a novel class of biphenyl CETP inhibitors
19. Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem
20. 2-Arylbenzoxazoles as CETP inhibitors: Substitution and modification of the α-alkoxyamide moiety
21. 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety
22. Synthesis and biological evaluation of platensimycin analogs
23. Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A
24. Tetrahydro anthranilic acid as a surrogate for anthranilic acid: Application to the discovery of potent niacin receptor agonists
25. Biphenyl-Substituted Oxazolidinones as Cholesteryl Ester Transfer Protein Inhibitors: Modifications of the Oxazolidinone Ring Leading to the Discovery of Anacetrapib
26. Discovery of Substituted Biphenyl Oxazolidinone Inhibitors of Cholesteryl Ester Transfer Protein
27. Corrigendum to “2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety” [Bioorg. Med. Chem. Lett. 20 (2010) 346]
28. ChemInform Abstract: Antibacterial Activity of G6-Quaternary Ammonium Derivatives of a Lipophilic Vancomycin Analogue.
29. Discovery of a Biaryl Cyclohexene Carboxylic Acid (MK-6892): A Potent and Selective High Affinity Niacin Receptor Full Agonist with Reduced Flushing Profiles in Animals as a Preclinical Candidate
30. Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats
31. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A
32. Androstene-3,5-dienes as ER-β selective SERMs
33. Novel glucocorticoids containing a 6,5-bicyclic core fused to a pyrazole ring: Synthesis, in vitro profile, molecular modeling studies, and in vivo experiments
34. Bridged androstenediol analogs as ER-β selective SERMs
35. Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα
36. Agonist-like SERM effects on ERα-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus
37. Discovery of Biaryl Anthranilides as Full Agonists for the High Affinity Niacin Receptor
38. Erratum to “Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists” [Bioorg. Med. Chem. Lett. 16 (2006) 4652–4656]
39. Tetrahydrofluorenones with conformationally restricted side chains as selective estrogen receptor beta ligands
40. Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists
41. 6H-Benzo[c]chromen-6-one Derivatives as Selective ERβ Agonists.
42. Androstenediol analogs as ER-β-selective SERMs
43. Estrogen receptor ligands. Part 14: Application of novel antagonist side chains to existing platforms
44. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain
45. Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity
46. Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy
47. Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs
48. In Vitro Bioactivation of Dihydrobenzoxathiin Selective Estrogen Receptor Modulators by Cytochrome P450 3A4 in Human Liver Microsomes: Formation of Reactive Iminium and Quinone Type Metabolites
49. Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans
50. Estrogen Receptor Ligands. 12. Synthesis of the Major Metabolites of an ERα-Selective, Dihydrobenzoxathiin Antagonist for Osteoporosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.